(Q46639393)

English

Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation

scientific article published in May 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

0 references

Cytomegalovirus

0 references

1 reference

based on heuristic

inferred from title

cytomegaloviral disease

1 reference

based on heuristic

inferred from title

Thomas Stamminger

6

object named as

Thomas Stamminger

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

9

object named as

Thomas Efferth

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

author name string

Michael Y Shapira

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

Igor B Resnick

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

Sunwen Chou

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

Avidan U Neumann

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

Nell S Lurain

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

Orit Caplan

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

Niveen Saleh

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

Manfred Marschall

10

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

Dana G Wolf

11

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

language of work or name

0 references

publication date

1 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

46

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

9

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

1455-1457

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1086%2F587106

21 January 2018

Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1086%2F587106

21 January 2018

Human cytomegalovirus resistance to antiviral drugs

1 reference

https://api.crossref.org/works/10.1086%2F587106

21 January 2018

Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs

1 reference

https://api.crossref.org/works/10.1086%2F587106

21 January 2018

Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates

1 reference

https://api.crossref.org/works/10.1086%2F587106

21 January 2018

Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects

1 reference

https://api.crossref.org/works/10.1086%2F587106

21 January 2018

Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses.

1 reference

https://api.crossref.org/works/10.1086%2F587106

21 January 2018

The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1086%2F587106

21 January 2018

Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.

1 reference

https://api.crossref.org/works/10.1086%2F587106

21 January 2018

The dynamics of human cytomegalovirus replication in vivo

1 reference

https://api.crossref.org/works/10.1086%2F587106

21 January 2018

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1086%2F587106

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18419454

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46639393&oldid=2123634359"